PetCaseFinder

Peer-reviewed veterinary case report

Dog survival after surgery for congenital liver shunts

By Parker, Jacquelyn S et al.·Published in Journal of the American Veterinary Medical Association·2008·Department of Clinical Sciences, United States·View original on PubMed

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Histologic examination of hepatic biopsy samples as a prognostic indicator in dogs undergoing surgical correction of congenital portosystemic shunts: 64 cases (1997-2005).

Species:
dog

Plain-English summary

A group of 64 dogs with congenital portosystemic shunts (PSS) underwent surgery to correct the condition, and their liver biopsy samples were examined to see if they could predict survival time. After an average follow-up of nearly three years, the median survival time was about 50 months, with some dogs living longer and others passing away due to complications related to the PSS or unrelated causes. However, the study found that the specific liver abnormalities seen in the biopsy samples did not help predict how long the dogs would survive after surgery.

People also search for: dog portosystemic shunt surgery outcome · liver biopsy results in dogs · congenital liver shunt prognosis

Abstract

OBJECTIVE: To determine whether results of histologic examination of hepatic biopsy samples could be used as an indicator of survival time in dogs that underwent surgical correction of a congenital portosystemic shunt (PSS). DESIGN: Retrospective case series. ANIMALS: 64 dogs that underwent exploratory laparotomy for an extrahepatic (n = 39) or intrahepatic (25) congenital PSS. PROCEDURES: All H&E-stained histologic slides of hepatic biopsy samples obtained at the time of surgery were reviewed by a single individual, and severity of histologic abnormalities (ie, arteriolar hyperplasia, biliary hyperplasia, fibrosis, cell swelling, lipidosis, lymphoplasmacytic cholangiohepatitis, suppurative cholangiohepatitis, lipid granulomas, and dilated sinusoids) was graded. A Cox proportional hazards regression model was used to determine whether each histologic feature was associated with survival time. RESULTS: Median follow-up time was 35.7 months, and median survival time was 50.6 months. Thirty-eight dogs were alive at the time of final follow-up; 15 had died of causes associated with the PSS, including 4 that died immediately after surgery; 3 had died of unrelated causes; and 8 were lost to follow-up. None of the histologic features examined were significantly associated with survival time. CONCLUSIONS AND CLINICAL RELEVANCE: Findings suggested that results of histologic examination of hepatic biopsy samples obtained at the time of surgery cannot be used to predict long-term outcome in dogs undergoing surgical correction of a PSS.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/18479241/